Purdue Pharma faces final sentencing

A federal judge has sentenced OxyContin maker Purdue Pharma to pay over $5 billion in criminal penalties, clearing the final legal hurdle for the company's dissolution.

The sentencing follows a massive settlement intended to resolve thousands of lawsuits over the company's role in the opioid crisis.

Purdue Pharma is expected to be dissolved by the end of the week and replaced by a new company focused on public health.

Families of opioid victims expressed mixed emotions following the court's decision.